ZNF250 and cancer: A case in point is Feng et al., who evidenced that cancer-associated fibroblast (CAF)-derived exosomes deliver ZNF250 protein to HCC cells, upregulating PD-L1 expression to suppress CD8+ T cell activity while enhancing tumor proliferation, migration, and invasion (37).